Twenty percent better with 20 micrograms? A qualitative study of psychedelic microdosing self-rapports and discussions on YouTube
Analysis of YouTube self‑reports and comments found that users predominantly describe therapeutic and enhancement benefits from psychedelic microdosing (mainly LSD and psilocybin), with notable improvements for depression and outcomes shaped by intentions and peer‑shared strategies. The study suggests microdosing may offer some benefits similar to full‑dose treatments with fewer acute adverse reactions, but repeated long‑term exposure could introduce additional risks.
Authors
- Andersson, M.
- Kjellgren, A.
Published
Abstract
Background
Psychedelic microdosing is the trending practice of using tiny repeated doses of psychedelic substances to facilitate a range of supposed benefits. With only a few published studies to date, the subject is still under-researched, and more knowledge is warranted. Social media and internet discussion forums have played a vital role in the growing visibility of the microdosing phenomenon, and the present study utilized YouTube contents to improve comprehension of the microdosing practice as well as the social interactions and discussions around microdosing.
Methods
Microdosing self-disclosure in YouTube videos and their following comments were qualitatively analyzed by inductive thematic analysis. Various software was utilized to enable gathering and sorting relevant data.
Results
Microdosing of psychedelic substances, primarily LSD and psilocybin, was used for therapeutic and enhancement purposes, and predominantly beneficial effects were reported. Many different applications and outcomes were discussed, and therapeutic effects for depression appeared especially noteworthy. Intentions for use were recognized as an influencing factor for the progression and outcomes of microdosing. The function of social interactions was mainly to discuss views on the microdosing phenomenon, strategies for optimal results, minimize risks, and share emotional support.
Conclusions
Potentially, microdosing could provide some of the same benefits (for certain conditions) as full-dose interventions with less risk of adverse reactions related to the sometimes intense experiences of higher doses. Microdosing may well also mean additional benefits, as well as risks, through the repeated exposure over extended periods.
Research Summary of 'Twenty percent better with 20 micrograms? A qualitative study of psychedelic microdosing self-rapports and discussions on YouTube'
Introduction
Psychedelic microdosing — the practice of taking repeated, very small doses of classic psychedelics such as LSD or psilocybin — has become highly visible in popular media and online communities but remains under‑researched. Andersson and Kjellgren note that aside from a small number of experimental studies (including one double‑blind, placebo‑controlled microdosing trial and several uncontrolled or self‑report investigations), most evidence comes from surveys and internet forums. Social media platforms, and YouTube in particular, have played a substantial role in spreading user reports, dosing strategies, and peer advice, creating a rich but methodologically challenging source of naturalistic data. This study set out to improve understanding of how psychedelic microdosing is presented and discussed on YouTube and to develop a practical method for using YouTube as a qualitative data source. The investigators aimed to characterise motives, reported effects, dosing approaches, and the social interactions that surround the practice, analysing first‑hand self‑reports in videos together with their comment threads using an inductive thematic approach.
Expert Research Summaries
Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.
Full Text PDF
Full Paper PDF
Create a free account to open full-text PDFs.
Study Details
- Study Typeindividual
- Journal
- Compounds
- Topics
- APA Citation
Andersson, M., & Kjellgren, A. (2019). Twenty percent better with 20 micrograms? A qualitative study of psychedelic microdosing self-rapports and discussions on YouTube. Harm Reduction Journal, 16(1). https://doi.org/10.1186/s12954-019-0333-3
References (17)
Papers cited by this study that are also in Blossom
Rucker, J., Young, A. H., Jelen, L. A. et al. · Journal of Psychopharmacology (2016)
Rucker, J., Iliff, J., Nutt, D. J. · Neuropharmacology (2017)
Carhart-Harris, R. L., Bolstridge, M., Rucker, J. et al. · Lancet Psychiatry (2016)
Dos Santos, R. G., Osório, F. L., Crippa, J. A. et al. · Therapeutic Advances in Psychopharmacology (2016)
Sweat, N. W., Bates, L. W., Hendricks, P. S. · Journal of Psychoactive Drugs (2016)
Nichols, C. D., Nichols, D. E., Johnson, M. W. · Clinical Pharmacology and Therapeutics (2016)
Yanakieva, S., Polychroni, N., Family, N. et al. · Psychopharmacology (2018)
Polito, V., Stevenson, R. J. · PLOS ONE (2019)
Anderson, T., Petranker, R., Rosenbaum, D. et al. · Psychopharmacology (2019)
Johnstad, P. G. · Nordic Studies on Alcohol and Drugs (2018)
Show all 17 referencesShow fewer
Fadiman, J., Korb, S. · Journal of Psychoactive Drugs (2019)
Andersson, M., Persson, M., Kjellgren, A. · Harm Reduction Journal (2017)
Johnson, M. W., Griffiths, R. R. · Neurotherapeutics (2017)
Olson, J. A. · Neuroscience Insights (2018)
Jungaberle, H., Thal, S., Zeuch, A. et al. · Neuropharmacology (2018)
Schindler, E. A. D., Gottschalk, C. H., Weil, M. J. et al. · Journal of Psychoactive Drugs (2015)
Sewell, R. A. · Neurology (2006)
Cited By (14)
Papers in Blossom that reference this study
Joy Donegan, C., Daldegan-Bueno, D., Sumner, R. L. et al. · Therapeutic Advances in Psychopharmacology (2025)
Murphy, R. J., Wardlaw, M., Smith, T. et al. · Journal of Humanistic Psychology (2025)
Modzelewski, S., Waszkiewicz, N., Lukasiewicz, K. et al. · Neuropharmacology (2025)
Murphy, R. J. · Psychopharmacology (2024)
Kiilerich, K. F., Lorenz, J., Scharff, M. B. et al. · Molecular Psychiatry (2023)
Murphy, R., Sumner, R. L., Evans, W. J. et al. · Biological Psychiatry (2023)
Pop, I., Dinkelacker, J. · Nordic Studies on Alcohol and Drugs (2023)
Pop, I., Dinkelacker, J. · Journal of Psychedelic Studies (2023)
Hartong, V., van Emmerik, A. · Journal of Psychoactive Drugs (2022)
Ferenstein, G. · SSRN (2022)
Show all 14 papersShow fewer
Haijen, E., Hurks, P. P. M., Kuypers, K. P. C. · Neuroscience Applied (2022)
Polito, V., Liknaitzky, P. · Psyarxiv (2021)
Dressler, H. M., Bright, S. J., Polito, V. · Journal of Psychedelic Studies (2021)
Ona, G., Bouso, J. C. · Neuroscience and Biobehavioral Reviews (2020)
Your Personal Research Library
Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.